15 Nov 2025 | 3 Mins Read
Alembic Pharma receives USFDA approval for diltiazem tablets
Flipitmoney
Alembic Pharmaceuticals received final USFDA approval for Diltiazem Hydrochloride Tablets USP in various strengths. The approval is for treating high blood pressure and angina, and the product is therapeutically equivalent to Cardizem Tablets by Bausch Health US, LLC. This marks Alembic's 210th final USFDA ANDA approval.